Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022

SELL
$120.42 - $169.29 $21,314 - $29,964
-177 Reduced 95.68%
8 $1,000
Q1 2022

May 11, 2022

BUY
$127.18 - $173.91 $635 - $869
5 Added 2.78%
185 $30,000
Q4 2021

Jan 10, 2022

SELL
$159.56 - $209.29 $18,030 - $23,649
-113 Reduced 38.57%
180 $31,000
Q3 2021

Nov 24, 2021

BUY
$169.75 - $207.73 $8,148 - $9,971
48 Added 19.59%
293 $55,000
Q2 2021

Jul 30, 2021

BUY
$128.63 - $176.89 $6,817 - $9,375
53 Added 27.6%
245 $42,000
Q1 2021

Apr 29, 2021

BUY
$126.83 - $175.69 $24,351 - $33,732
192 New
192 $27,000

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $31.3B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.